Revival Healthcare Capital led a $150m Series G round in Distalmotion.

Revival Healthcare Capital, an investment firm focused on scaling MedTech companies, led a $150m Series G round in Distalmotion, a developer of robotic surgery systems, with participation from existing investors. “This funding marks another important milestone on our journey. The continued commitment of our investors validates our vision to break down barriers to robotic access through simplified operations. As we enter our next phase of US market acceleration, ASCs represent a tremendous opportunity for DEXTER. The ongoing support from our investors reaffirms our roadmap, our mission, and the value DEXTER brings to minimally invasive surgery,” Greg Roche, Distalmotion CEO.